Abstract:Background: Numerous studies have demonstrated the influence of gut microbiota on the development of obesity. In this study, we utilized Mendelian randomization (MR) analysis to investigate the gut microbiota characteristics among different types of obese patients, aiming to elucidate the underlying mechanisms and provide novel insights for obesity treatment. Methods: Two-sample multivariable Mendelian randomization (MR) analysis was employed to assess causal relationships between gut microbiota and various obesity subtypes. Gut microbiota data were obtained from the international consortium MiBioGen, and data on obese individuals were sourced from the Finnish National Biobank FinnGen. Eligible single-nucleotide polymorphisms (SNPs) were selected as instrumental variables. Various analytical methods, including inverse variance weighted (IVW), MR-Egger regression, weighted median, MR-RAPS, and Lasso regression, were applied. Sensitivity analyses for quality control included MR-Egger intercept tests, Cochran's Q tests, and leave-one-out analyses and others. Results: Mendelian randomization studies revealed distinct gut microbiota profiles among European populations with different obesity subtypes. Following multivariable MR analysis, we found that Ruminococcaceae UCG010 [ Odds Ratio (OR) : 0.842, 95% confidence interval (CI) : 0.766-0.926, Adjusted P value: 0.028] independently reduced the risk of obesity induced by excessive calorie intake, while Butyricimonas [ OR : 4.252, 95% CI : 2.177-8.307, Adjusted P value: 0.002] independently increased the risk of medication-induced obesity. For localized adiposity, Pasteurellaceae [ OR : 0.213, 95% CI : 0.115-0.395, Adjusted P value: <0.001] acted as a protective factor. In the case of extreme obesity with alveolar hypoventilation, lactobacillus [ OR : 0.724, 95% CI : 0.609-0.860, Adjusted P value: 0.035] reduced the risk of its occurrence. Additionally, six gut microbiota may have potential roles in the onset of different types of obesity. Specifically, the Ruminococcus torques group may increase the risk of its occurrence. Desulfovibrio and Catenabacterium may serve as protective factors in the onset of Drug-induced obesity. Oxalobacteraceae , Actinomycetaceae , and Ruminiclostridium 9 , on the other hand, could potentially increase the risk of Drug-induced obesity. No evidence of heterogeneity or horizontal pleiotropy among SNPs was found in the above studies (all P values for Q test and MR-Egger intercept > 0.05). Conclusion: Gut microbiota abundance is causally related to obesity, with distinct gut microbiota profiles observed among different obesity subtypes. Four bacterial species, including Ruminococcaceae UCG010 , Butyricimonas , Pasteurellaceae and lactobacillus independently influence the development of various types of obesity. Probiotic and prebiotic supplementation may represent a novel approach in future obesity management.

The effect of heritability and host genetics on the gut microbiota and metabolic syndrome

Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis

Identification of genetic variants related to metabolic syndrome by next-generation sequencing

Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases

The effect of host genetics on the gut microbiome

A Metagenome-Wide Association Study of the Gut Microbiome and Metabolic Syndrome

Identification of shared genetic risks underlying metabolic syndrome and its related traits in the Korean population

Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome

Gut microbiota and host genetics modulate the effect of diverse diet patterns on metabolic health

The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases

Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort

Interplay between the human gut microbiome and host metabolism

Symbiotic gut microbes modulate human metabolic phenotypes

Gut microbiota-derived metabolites: implications for metabolic syndrome and therapeutic interventions

Relationships and Mendelian Randomization of Gut Microbe-Derived Metabolites with Metabolic Syndrome Traits in the METSIM Cohort

Unravelling the effects of the environment and host genotype on the gut microbiome

Large-scale association analyses identify host factors influencing human gut microbiome composition

Unraveling the mystery: a Mendelian randomized exploration of gut microbiota and different types of obesity

Multivariate genomic analysis of 5 million people elucidates the genetic architecture of shared components of the metabolic syndrome

Gut Microbiota and Metabolic Syndrome: Relationships and Opportunities for New Therapeutic Strategies

Role of the intestine and its gut microbiota in metabolic syndrome and obesity